Schwartz D, Billingsley K, Wallner K
Department of Radiation Oncology, Seattle VA Hospital-Puget Sound Health Care System, Washington, USA.
Oncology (Williston Park). 2000 Oct;14(10):1493-8, 1501; discussion 1502-5.
Posttreatment follow-up is a staple of oncologic practice. Clinicians have traditionally presumed that close surveillance improves clinical outcome. However, new evidence reveals that frequent, procedure-intensive follow-up may provide no more significant benefit to patients than simpler approaches. Several recent consensus recommendations from major oncology organizations support this theory. Published surveys of clinician and institutional follow-up policies reveal significant variations in practice, with many providers continuing to use costly, unproven regimens. This review highlights current data on follow-up care for three common cancers--breast, colorectal, and prostate. These data suggest an acute need for changes leading to more rational, consistent, and efficient follow-up practices.
治疗后的随访是肿瘤学实践的一项主要内容。传统上，临床医生认为密切监测可改善临床结果。然而，新证据表明，频繁的、程序密集型的随访可能并不比更简单的方法给患者带来更大的益处。主要肿瘤学组织最近的几项共识性建议支持了这一理论。已发表的关于临床医生和机构随访政策的调查显示，实践中存在显著差异，许多医疗服务提供者继续使用昂贵的、未经证实的方案。本综述重点介绍了三种常见癌症——乳腺癌、结直肠癌和前列腺癌——随访护理的当前数据。这些数据表明迫切需要做出改变，以实现更合理、一致和高效的随访实践。
